Poland· PL-100450240

Magnefar B6

A magnesium citrate product containing magnesii citras + pyridoxini hydrochloridum, registered in Poland by Biofarm Sp. z o.o.. The same ATC class is registered in 8 of our 19 countries.

ATC A12CC04

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about magnesii citras + pyridoxini hydrochloridumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Magnesium citrate is registered in 8 of 19 countries.

Countries holding a registration under ATC A12CC04 (magnesium citrate), each read from that country’s own register.

This record: Poland, from URPL (Poland)
5 of them publish a price we can compare per daily dose

Search magnesium citrate products by name

Magnesium citrate · ATC A12CC04

8 / 19 countries

Belgiumprice
Denmark
Finlandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of magnesium citrate costs, country by country.

Normalised to the WHO defined daily dose (2 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Magnesium citrate · price per daily dose (2 g)

USD · FX 28 Sept 2026

CH Switzerland$6.99

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Magnesii citras + Pyridoxini hydrochloridum
Manufacturer: Biofarm Sp. z o.o.
Country: Poland (PL)
ATC code: A12CC04
ATC class: Magnesium citrate
Defined daily dose: 2 g, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 7

gtin
05909991528966
gtin
05909991528980
gtin
05909991529017
gtin
05909991529024
gtin
05909991529000
gtin
05909991528973
gtin
05909991528997

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

305 interactions on record for magnesium citrate.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check magnesium citrate against other medicines How interaction checks work

Magnesium citrate · interactions on record

305 records

4 severe
287 moderate
1 minor

Most severe, free to view

DolutegravirJ05AJ03severe
DolutegravirJ05AX12severe
ErdafitinibL01EN01severe
ErdafitinibL01EX16severe

13 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Magnesium citrate in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All magnesium citrate products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

Bulgaria · Магне B6
Czechia · Magne B6
Estonia · Magne B6
France · Magne B6, Magnesium/Vitamine B6 Biogaran Conseil
Greece · Evrima-B6
Hungary · Magne B6, Magne B6 Forte
Lithuania · Magne B6
Latvia · Magne B6, Magne B6 Premium
Malta · Magnevie B6
Romania · Magne B6, Magne B6 Forte
Slovakia · Magne B6

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b39bc357-6e62-4ba7-8213-1f4371b95664
GET /v1/drugs/b39bc357-6e62-4ba7-8213-1f4371b95664?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "50 mg jonów magnezu Mg2+ + 5,05 mg",
  "packaging": "05909991528966 ¦ OTC ¦ 150473\n30 tabl.\n05909991528980 ¦ OTC ¦ 150474\n50 tabl.\n05909991529017 ¦ OTC ¦ 150475\n60 tabl.\n05909991529024 ¦ OTC ¦ 150476\n90 tabl.\n05909991529000 ¦ OTC ¦ 150477\n10 tabl.\n05909991528997 ¦ OTC ¦ 150478\n20 tabl.\n05909991528973 ¦ OTC ¦ 150479\n120 tabl.",
  "substance": "Magnesii citras 318.5 mg + Pyridoxini hydrochloridum 5.05 mg",
  "common_name": "Magnesii citras + Pyridoxini hydrochloridum",
  "pl_product_id": "100450240",
  "pozwolenie_nr": "28186",
  "auth_procedure": "NAR",
  "authorisation_validity": "2029-01-05"
}

API reference MCP server Plans

See everything about magnesium citrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console